The Center for Intellectual Property and Technology Law held the 2018 Scholar’s Roundtable “New Perspectives on IP and Health: Conversations about Law and Society” at Jindal Global Law School (JGLS) in Sonipat, India. The roundtable offered an opportunity to discuss new societal concerns with a focus on the intersection of intellectual property and health.
The roundtable began with a presentation by Sunita Tripathy, Associate Professor at JGLS, who discussed the appropriate placement of social justice within the narrative of health-regulation. Dmitry Karshtedt, Associate Professor of Law, presented next on the practical understandings of health regulation and provided a critical overview of the United States’ approach to regulating the practice of ‘product hopping’ by pharmaceutical patent owners. His paper, “The More Things Change: Improvement Patents, Drug Modifications and the FDA,” offers solutions to enhance transparency in pharmaceutical research and marketing by empowering the Food and Drug Administration to induce pharmaceutical companies to generate comparative data indicative of therapeutic distinctiveness between related versions of drugs.
Professor Karshtedt’s presentation was followed by a Q&A, “IP Expressions working group,” presentations from JGLS students, and closing remarks from Aashita Dawer, Associate Professor at JGLS.